Red Cell Distribution Width (RDW) as a Prognostic Marker in ICU

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02917811

Enrollment

250

Registered

2016-09-28

Start date

2016-01-31

Completion date

2016-11-30

Last updated

2017-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biochemical Marker, Blood Transfusion

Brief summary

The aim of this study is to verify if high values of RDW are useful prognostic marker for ICU mortality and 90-days mortality. Moreover, we will investigate the prognostic value of RDW in specific subgroup population with some clinical characteristic wich may modify RDW baseline values, i.e. transfused patients or patients with high markers of hemolysis

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Unselected ICU patients

Exclusion criteria

* Length of stay in ICU \<48 hours * Hematological disease * Age \<18 years

Design outcomes

Primary

Measure	Time frame
90-days mortality	90 days

Secondary

Measure	Time frame
ICU mortality	90 days
Length of mechanical ventilation	90 days

Countries

Italy

Outcome results